Back
Vision Lithium Vs. Nektar Therapeutics Industry Stock Comparison
Sell
18
ABEPF
Vision Lithium
Last Price:
$0.0200
Seasonality Move:
5.48%
Buy
51
NKTR
Nektar Therapeutics
Last Price:
$25.58
Seasonality Move:
4.65%
Sell
18
Vision Lithium (ABEPF)
is a Sell
Is Vision Lithium a Buy, Sell or Hold?
-
The current Vision Lithium [ABEPF] share price is $0.0150. The Score for ABEPF is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
-
ABEPF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
51
Nektar Therapeutics (NKTR)
is a Buy
Is Nektar Therapeutics a Buy, Sell or Hold?
-
The current Nektar Therapeutics [NKTR] share price is $23.60. The Score for NKTR is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
-
NKTR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ABEPF Stock Price Chart
What is Vision Lithium's stock price today?
-
The Vision Lithium share price today is $0.0150Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ABEPF is experiencing selling pressure, which indicates risk of future bearish movement.
NKTR Stock Price Chart
What is Nektar Therapeutics's stock price today?
-
The Nektar Therapeutics share price today is $23.60Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NKTR is experiencing slight buying pressure.
ABEPF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0 | Sell |
Relative Strength Index (14 RSI): | 45.07 | Sell |
Chaikin Money Flow: | -12229 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.0166 - 0.0166) | Sell |
Bollinger Bands (100): | (0.016 - 0.016) | Sell |
NKTR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.43 | Buy |
Relative Strength Index (14 RSI): | 54.83 | Buy |
Chaikin Money Flow: | 500230 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (22.53 - 24.97) | Sell |
Bollinger Bands (100): | (8.15 - 21.99) | Buy |
ABEPF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.02 | Sell |
20-day SMA: | 0.02 | Sell |
50-day SMA: | 0.02 | Sell |
200-day SMA: | 0.02 | Sell |
8-day EMA: | 0.02 | Sell |
20-day EMA: | 0.02 | Sell |
50-day EMA: | 0.02 | Sell |
200-day EMA: | 0.02 | Sell |
NKTR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 22.77 | Buy |
20-day SMA: | 23.6 | Sell |
50-day SMA: | 19.92 | Buy |
200-day SMA: | 15.01 | Buy |
8-day EMA: | 22.89 | Buy |
20-day EMA: | 22.9 | Buy |
50-day EMA: | 20.46 | Buy |
200-day EMA: | 16.32 | Buy |
Vision Lithium Earnings Growth & ABEPF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Nektar Therapeutics Earnings Growth & NKTR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.01 per share, an increase this year of $2.16 per share, and a decrease next year of $1.84 per share.
Vision Lithium Technical Analysis
Jul 30 | Jul 31 | Aug 1 | Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | Aug | |||||||||
30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Nektar Therapeutics Technical Analysis
Jul 30 | Jul 31 | Aug 1 | Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | Aug | |||||||||
30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |